Sulforaphane protects liver injury induced by intestinal ischemia reperfusion through Nrf2-ARE pathway

doi:10.3748/wjg.v16.i24.3002

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 24

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5376)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series.

Item

Count

PDF

617

HTML

4523

Figures (1-9)

236

Sum=5376

Jun 28, 2010 (publication date) through Jan 7, 2025

Times Cited of This Article

Times Cited (89)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jun 28, 2010; 16(24): 3002-3010
Published online Jun 28, 2010. doi: 10.3748/wjg.v16.i24.3002

Full Size Figure Download Figure

Figure 3 Liver tissue superoxide dismutase (SOD) (mean ± SD, U/mgprot) and myeloperoxidase (MPO) (mean ± SD, U/g) level in the control (A), SFN control (B), intestinal I/R (C) (1 h ischemia and 2 h reperfusion) and SFN pretreatment (D) groups. ^bP < 0.01 vs control group; ^dP < 0.01 vs intestinal I/R group.

Citation: Zhao HD, Zhang F, Shen G, Li YB, Li YH, Jing HR, Ma LF, Yao JH, Tian XF. Sulforaphane protects liver injury induced by intestinal ischemia reperfusion through Nrf2-ARE pathway. World J Gastroenterol 2010; 16(24): 3002-3010
URL: https://www.wjgnet.com/1007-9327/full/v16/i24/3002.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i24.3002